MaxPro Medical
As Seoul navigates its transition into a "super-aging society," the demand for Point-of-Care Testing (POCT) has transitioned from a luxury to a critical infrastructure requirement. The Seoul Metropolitan Government's 'Smart Healthcare' initiative is driving the integration of handheld cholesterol meters into community health centers and home-based monitoring systems.
For suppliers and medical distributors in Seoul, the "Information Gain" lies in understanding that accuracy (CV < 5%) is no longer the only benchmark. The new frontier is Data Interoperability—the ability of a cholesterol meter to sync seamlessly via Bluetooth or 5G with local HIS (Hospital Information Systems) and the National Health Insurance Service (NHIS) platforms.
The next generation of cholesterol monitoring in the Korean market involves Non-Invasive Spectroscopic Analysis and AI-driven Predictive Analytics. Our R&D pipeline is currently focusing on multi-analyte biosensors that can detect LDL, HDL, and Triglycerides from a single 10μL drop of blood, utilizing advanced dry-chemistry electrochemical methods to ensure clinical-grade precision in any environment—from a Gangnam private clinic to a home in Songpa-gu.
Strategically located in Shenzhen, MaxPro Medical leverages a "Supply Chain 4.0" model to serve the Seoul market with unprecedented speed. Our proximity to the global electronics hub allows for rapid prototyping and iterative updates to our BIOS and sensor tech.





Founded in 2009, Shenzhen MaxPro Medical Co., Ltd. is a leading manufacturer specializing in advanced medical devices and chronic disease monitoring solutions. With a strong commitment to innovation, quality, and customer satisfaction, we provide reliable healthcare technologies to over 500 healthcare institutions and distributors worldwide, with a specialized focus on the Seoul Metropolitan Market.
Our company operates a modern 20,000 sq ft manufacturing facility certified under ISO 13485 quality management standards. All our products comply with international medical regulations, with key products receiving FDA 510(k) clearance and CE certification.
Strict quality control from raw material sourcing to final product inspection ensures consistent production standards for Seoul's medical industry.
Professional R&D team providing flexible OEM/ODM solutions tailored to the unique needs of Korean healthcare providers.
Fast technical assistance and local logistics support to ensure efficient healthcare delivery across the Seoul market.
Our meters utilize advanced electrochemical biosensors with a Coefficient of Variation (CV) of less than 5%, matching the standards required for clinical-grade Point-of-Care Testing (POCT) in Korea. We conduct extensive cross-calibration with laboratory-grade analyzers (like those from Roche or Abbott) to ensure data reliability.
Yes, we provide full localization support, including Korean-language firmware and user manuals. Furthermore, our devices can be equipped with Bluetooth modules that support data export in formats compatible with HL7 and other common electronic health record (EHR) standards used in Seoul hospitals.
Our Factory 4.0 system integrates real-time inventory and logistics monitoring. For Seoul-based clients, this means a reduction in lead times by 30% compared to traditional manufacturers, and the ability to fulfill "Just-In-Time" orders during peak healthcare seasons.
Consistency in strip supply is our priority. We maintain a dedicated production line for test strips with a monthly capacity of over 5 million units, ensuring that Seoul healthcare providers never face shortages.